Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TCEAL2 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | RALGDS | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | RUNDC3A | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | ZNF527 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | FANCF | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | FGL2 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | FAM69B | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | PBRM1 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
mRNA | NOB1 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
mRNA | CBX2 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |